Management of adverse events in TB care and active TB drug safety monitoring.
Tuberculosis (TB) remains the leading cause of death from a single infectious agent, with 10.8 million cases reported in 2023. While treatment is generally effective, both drug-susceptible (DS-TB) and drugresistant TB (DR-TB) regimens are associated with adverse events (AEs) that compromise adherenc...
| Publicado en: | Breathe Vol. 22; no. 1; pp. 1 - 11 |
|---|---|
| Autores principales: | , , , , , |
| Formato: | tables/charts Journal Article |
| Publicado: |
European Respiratory Society
Jan2026
|
| Acceso en línea: | Ver este registro en EBSCOhost |